Apogee Therapeutics, Inc. · NASDAQ:APGE
Peter Evan Harwin reported a 9.99% stake in Apogee Therapeutics, Inc. (Schedule 13D/A)
Event Mar 26, 2026 · Filed Mar 27, 2026
Peter Evan Harwin reported a 9.99% stake in Apogee Therapeutics, Inc., 6,764,974 shares, with active intent on Mar 26, 2026. Filed Mar 27, 2026 (Schedule 13D/A).
- Stake
- 9.99%
- Shares
- 6,764,974
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Fairmount Funds Management LLC | 9.84% | 6,666,332 |
| Fairmount Healthcare Fund II L.P. | 9.84% | 6,666,332 |
| Peter Evan Harwin | 9.99% | 6,764,974 |
| Tomas Kiselak | 9.99% | 6,764,974 |
Source
Related
- Apogee Therapeutics, Inc.
- Harwin Peter Evan
- Apogee Therapeutics, Inc. shareholders
- Schedule 13D/A · Harwin Peter Evan · Jun 23, 2026
- Schedule 13D/A · Harwin Peter Evan · Jan 22, 2026
- Schedule 13D/A · Harwin Peter Evan · Oct 14, 2025
- Schedule 13D/A · Venrock Healthcare Capital Partners III, L.P. · Sep 8, 2026
- Form 4 · Fairmount Funds Management LLC · Sep 3, 2026
- Form 4 · McKenna Mark C. · Sep 3, 2026
- Form 4 · Jones William A Jr · Sep 3, 2026
- Form 4 · Dambkowski Carl · Sep 3, 2026